肝病患者静注前列腺素E1致静脉炎原因分析  

Analysis on the causes of intravenous injection of prostaglandin E1to phlebitis in patients with liver disease

作　　者：刘淑萍[1] 李嫦珍[1] LIU Shu-ping;LI Chang-zhen(Health Management Center, Pan’an County People’s Hospital, Pan’an 322300, China)

机构地区：[1]磐安县人民医院健康管理中心,浙江磐安322300

出　　处：《中国生化药物杂志》2017年第11期379-380,382,共3页Chinese Journal of Biochemical Pharmaceutics

摘　　要：目的分析肝病患者静脉注射前列腺素E1致静脉炎的原因及对策。方法回顾性分析磐安县人民医院2015年1月～2017年6月肝病患者静脉注射前列腺素E1致静脉炎的患者562例，对性别、年龄、发生时间、发生的程度、处理和转归进行分析。结果51例前列腺素E1静脉炎患者中，男32例，女19例，平均年龄（56±6.7）岁，静脉炎年龄分布主要发生在50～59岁和60～69岁年龄段，分别占27.4%和41.3%。静脉炎发生时间主要在输液过程中，共22例（43.2%）。51例静脉炎患者发生程度：1级35例（68.6%），2级13例（25.5%），3级3例（5.9%），4级无发生。51例静脉炎转归：44例治愈，7例好转。结论肝病患者静脉注射前列腺素E1所致致静脉炎，经对症处理和治疗，可以治愈或好转，并可以预防。Objective To analyze the causes and countermeasures of intravenous injection of prostaglandin E1to phlebitis in patients with liver disease.Methods562cases of liver disease patients with venous injection of prostaglandin E1phlebitis caused by patients in our hospital were retrospectively analyzed from January2015to June2017,in gender,age,time,degree,treatment and outcome were analyzed.Results51cases of prostaglandin E1in patients with phlebitis,32cases of male,female19cases,the average age was(56±6.7),and phlebitis age distribution mainly in50to59years old and60-69age group,27.4%and41.3%respectively.The time of phlebitis occurred mainly in22cases,accounting for43.2%.The degree of occurrence of51cases of phlebitis:level1,35cases(68.6%),grade2,13cases(25.5%),3cases in3cases(5.9%),and grade4had no one.51cases of phlebitis were regrouped:44cases were cured and7were better.Conclusion The intravenous injection of prostaglandin E1in patients with liver disease can cause phlebitis,which can be cured or improved by treatment and treatment,and can be prevented.

关 键 词：肝病 前列腺素E1 静脉炎 相关因素 

分 类 号：R472[医药卫生—护理学]